News 17 Nov 2022 Daxor Corporation Announces Closing of $2.1 million Underwritten Public Offering and Exercise of Over-Allotment Option admin
News 15 Nov 2022 Daxor Corporation Announces Pricing of $2.0 million Underwritten Public Offering admin
News 10 Nov 2022 Live Webinar by MedAxiom Features Best Practices Using Daxor’s Blood Volume Analysis (BVA-100®) to Improve Heart Failure Outcomes & Reduce Costs admin
News 03 Nov 2022 Newly Published Study Demonstrates Significant Clinical Utility of Daxor’s Blood Volume (BVA-100®) Diagnostic in the Evaluation of Heart Failure admin
